This Week in Pediatrics
FDA news in pediatrics: August 2026 | Contemporary Pediatrics
On August 19, 2026, the FDA accepted Teva's New Drug Application and granted priority review to ecopipam, a first-in-class selective dopamine D1 receptor antagonist, for pediatric Tourette syndrome, with a target action date in late Q1 2027.
Contemporary Pediatrics – Clinical News & Pediatrician Practice Tips
Chronic skin conditions linked to bullying, depression, and suicide risk in children, adolescents · Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and ...
Newsroom | About Children's Health
Our team attended the @PediAnesthesia 2026 Conference in Denver, sharing our expertise, engaging with leaders from across the country and showcasing the momentum behind our pediatric anesthesia program.
Research of the Day
Early Peanut Introduction: 8-Year Outcomes from the LEAP Trial Extension
Extended follow-up of the landmark LEAP trial confirms sustained peanut allergy protection 8 years after early introduction, even when children stopped regular peanut consumption. The protective effect persists regardless of continued consumption.
Key findings: (1) 74% reduction in peanut allergy maintained at 8 years; (2) Protection sustained even after 12-month period of avoiding peanuts; (3) Early introduction (4-6 months) most effective for high-risk infants.
Reinforce early peanut introduction guidance, especially for infants with eczema or egg allergy. Recommend 2g peanut protein, 3 times weekly starting at 4-6 months in appropriate form.
Popular Beliefs
Cold weather causes colds
What the evidence shows: Colds are caused by viruses, not cold temperatures. The association exists because people spend more time indoors in close proximity during winter, facilitating viral transmission. Additionally, dry indoor air may impair mucosal barriers. Hand hygiene and avoiding sick contacts are the real prevention strategies.
Green mucus means bacterial infection requiring antibiotics
What the evidence shows: Mucus color changes naturally during viral infections and does not reliably distinguish viral from bacterial causes. Green/yellow mucus indicates immune cell activity, which occurs in both viral and bacterial infections. Antibiotics should be prescribed based on clinical criteria, not mucus color.
Too many vaccines overwhelm a child's immune system
What the evidence shows: Children's immune systems handle vastly more antigens daily from the environment than from vaccines. Today's vaccines contain far fewer antigens than older versions despite protecting against more diseases. Studies show no increased infection rates in vaccinated children—vaccines strengthen, not weaken, immunity.
Behaviors
Screen Time and Executive Function in Preschoolers: A Longitudinal Analysis
This prospective cohort study followed 850 children from ages 2 to 5 years, examining the relationship between screen time exposure and executive function development. Researchers used validated parent-report measures and direct assessments of working memory, inhibitory control, and cognitive flexibility.
Children with more than 2 hours of daily screen time at age 2 showed lower scores on executive function measures at age 5. Notably, the type of screen content mattered—educational programming showed smaller associations than passive entertainment viewing. Joint parent-child viewing partially mitigated negative effects.
These findings support counseling families on the AAP recommendation of less than 1 hour per day of high-quality programming for children 2-5 years. Emphasize co-viewing and educational content when screens are used. Executive function is crucial for school readiness and later academic success.
Genetics
CRISPR Gene Editing for Sickle Cell Disease: Long-Term Follow-Up
Long-term data from CRISPR-edited sickle cell patients shows durable remission of vaso-occlusive crises in 95% of treated patients at 4-year follow-up. The one-time treatment has transformed the disease trajectory for participants.
Key findings: (1) No vaso-occlusive crises in 95% of patients; (2) Hemoglobin levels maintained in normal range; (3) No off-target editing effects detected. Access and affordability remain challenges.
Curative therapy for sickle cell disease is now reality, though access barriers remain. Stay informed about treatment centers and insurance coverage in your area. Early referral for evaluation is appropriate.